Search Results for "days"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for days. Results 1 to 10 of 1849 total matches.

Tadalafil (Cialis) Once a Day for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Apr 07, 2008  (Issue 1283)
Tadalafil (Cialis) Once a Day for Erectile Dysfunction ...
The phosphodiesterase type 5 (PDE5) inhibitor tadalafil (Cialis - Lilly) is now being promoted for once daily treatment of erectile dysfunction. Tadalafil differs from sildenafil (Viagra) and vardenafil (Levitra), the other PDE5 inhibitors marketed for erectile dysfunction in the US, in having a much longer duration of action.
Med Lett Drugs Ther. 2008 Apr 7;50(1283):27-8 |  Show IntroductionHide Introduction

Antibacterial Drugs for Lyme Disease

   
The Medical Letter on Drugs and Therapeutics • May 17, 2021  (Issue 1624)
of the tick bite in about 80% of patients with early disease. It usually appears 1-2 weeks (range 3-30 days ...
Lyme disease in the US is caused by the spirochete Borrelia burgdorferi, which is transmitted to humans by Ixodes scapularis (blacklegged [deer] tick) and I. pacificus (western blacklegged tick). Most cases of Lyme disease occur in late spring and early summer in northeastern and mid-Atlantic states, the upper Midwest, and in northern California. B. mayonii, which is also transmitted by I. scapularis, has been shown to cause a similar illness in the upper Midwest.
Med Lett Drugs Ther. 2021 May 17;63(1624):73-5 |  Show IntroductionHide Introduction

Remdesivir (Veklury) for COVID-19

   
The Medical Letter on Drugs and Therapeutics • Nov 30, 2020  (Issue 1612)
days, in addition to standard treatment. About 15% of patients had mild to moderate disease and 85% had ...
The FDA has approved the antiviral drug remdesivir (Veklury – Gilead) for IV treatment of COVID-19 in hospitalized patients who are ≥12 years old and weigh ≥40 kg. Hospitalized children who are <12 years old or weigh <40 kg can receive remdesivir through an Emergency Use Authorization (EUA). Remdesivir is the first drug to be approved in the US for treatment of COVID-19.
Med Lett Drugs Ther. 2020 Nov 30;62(1612):186-8 |  Show IntroductionHide Introduction

Comparison Table: Some Oral Drugs for Allergic Rhinitis (online only)

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025  (Issue 1725)
and caps; 10 mg disintegrating tabs; 5 mg/5 mL syrup OTC 10 mg once/day 6-11 mos: 2.5 mg once/day3 12 ...
View the Comparison Table: Some Oral Drugs for Allergic Rhinitis
Med Lett Drugs Ther. 2025 Mar 31;67(1725):e55-7   doi:10.58347/tml.2025.1725b |  Show IntroductionHide Introduction

Comparison Table: Some Nonopioid Analgesics for Pain (online only)

   
The Medical Letter on Drugs and Therapeutics • Mar 07, 2022  (Issue 1645)
mg q4-6h or 1000 mg q6h 1300 mg q8h4 (max 4000 mg/day) 650 mg q4-6h (max 4000 mg/day) ...
View the Comparison Table: Some Nonopioid Analgesics for Pain
Med Lett Drugs Ther. 2022 Mar 7;64(1645):e40-3 |  Show IntroductionHide Introduction

Choice of Contraceptives

   
The Medical Letter on Drugs and Therapeutics • May 15, 2023  (Issue 1676)
hormones varies throughout the 28-day cycle. Many multiphasic pills deliver a lower total hormone dose ...
Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also effective in preventing pregnancy. When used alone, barrier and behavioral methods generally have higher failure rates than other methods (see Table 1). Selection of a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80   doi:10.58347/tml.2023.1676a |  Show IntroductionHide Introduction

A Donepezil Patch (Adlarity) for Alzheimer's Disease (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 08, 2022  (Issue 1656)
, 10 mg/day patches Route Transdermal Metabolism Primarily by CYP2D6, 3A4, and glucuronidation ...
A once-weekly transdermal formulation of the acetylcholinesterase inhibitor donepezil (Adlarity – Corium) has been approved by the FDA for treatment of mild, moderate, and severe Alzheimer's disease (AD) dementia. Donepezil is the second acetylcholinesterase inhibitor to become available in a transdermal formulation; transdermal rivastigmine (Exelon Patch), which is applied once daily, has been available for years for the same indication. Donepezil is also available in oral formulations (Aricept, and generics) for treatment of AD dementia.
Med Lett Drugs Ther. 2022 Aug 8;64(1656):e128-9 |  Show IntroductionHide Introduction

Treatment of COVID-19 in High-Risk Outpatients (online only)

   
The Medical Letter on Drugs and Therapeutics • Jan 28, 2022  (Issue 1643)
: 300/100 mg3 PO bid x 5 days • Begin ≤5 days after symptom onset • Age/Weight Requirements: ≥12 years ...
View the Treatment of COVID-19 in High-Risk Outpatients Chart
Med Lett Drugs Ther. 2022 Jan 28;64(1643):e1 |  Show IntroductionHide Introduction

Ibrexafungerp (Brexafemme) for Vulvovaginal Candidiasis

   
The Medical Letter on Drugs and Therapeutics • Sep 06, 2021  (Issue 1632)
recurrences, induction therapy with an intravaginal azole for 7-14 days or 3 doses of oral fluconazole (150 ...
The FDA has approved ibrexafungerp (Brexafemme – Scynexis), a first-in-class triterpenoid antifungal ("fungerp"), for oral treatment of vulvovaginal candidiasis in postmenarchal females.
Med Lett Drugs Ther. 2021 Sep 6;63(1632):141-3 |  Show IntroductionHide Introduction

Treatment of Common Respiratory Tract Infections

   
The Medical Letter on Drugs and Therapeutics • Apr 17, 2023  (Issue 1674)
amplification test. Standard Treatment – Patients who test positive for GAS should be treated with a 10-day ...
Most respiratory tract infections are caused by viruses. Bacterial respiratory tract infections are usually treated empirically with antibiotic therapy that targets the most probable causative pathogens. Recommended antibiotic regimens for outpatient treatment of some common respiratory tract infections are listed in Table 1 for adults and Table 2 for children.
Med Lett Drugs Ther. 2023 Apr 17;65(1674):57-62   doi:10.58347/tml.2023.1674a |  Show IntroductionHide Introduction